HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Schönenberger Selected Research

ethylenediamine (ethylenediamine dihydroiodide)

10/2001Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound.
4/20011-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.
12/2000Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice.
11/2000[Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 3. Investigation of breast cancer inhibiting properties.
3/2000Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplat inum (II) inhibits this process.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Schönenberger Research Topics

Disease

6Breast Neoplasms (Breast Cancer)
10/2001 - 03/2000
5Neoplasms (Cancer)
10/2001 - 11/2000

Drug/Important Bio-Agent (IBA)

5ethylenediamine (ethylenediamine dihydroiodide)FDA Link
10/2001 - 03/2000
4Hormones (Hormone)IBA
04/2001 - 03/2000
3PlatinumIBA
10/2001 - 11/2000
3Immunologic Factors (Immunomodulators)IBA
04/2001 - 03/2000
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2001 - 12/2000
2DNA (Deoxyribonucleic Acid)IBA
10/2001 - 11/2000
2Pharmaceutical PreparationsIBA
10/2001 - 11/2000
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10/2001 - 12/2000
2Estrogens (Estrogen)FDA Link
04/2001 - 11/2000
1(meso- 1,2- bis- (2,6- dichloro- 4- hydroxyphenyl)ethylenediamine)dichloroplatinum(II)IBA
10/2001
1Estrogen ReceptorsIBA
10/2001
1Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2000
1Cisplatin (Platino)FDA LinkGeneric
11/2000
1ThymidineIBA
11/2000
1ovexIBA
11/2000

Therapy/Procedure

1Therapeutics
04/2001
1Splenectomy
12/2000